PortfoliosLab logoPortfoliosLab logo
PBPH vs. NZAC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PBPH vs. NZAC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) and SPDR MSCI ACWI Climate Paris Aligned ETF (NZAC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PBPH achieves a -1.13% return, which is significantly lower than NZAC's 8.83% return.


PBPH

1D
0.58%
1M
0.07%
YTD
-1.13%
6M
-0.02%
1Y
3Y*
5Y*
10Y*

NZAC

1D
-0.82%
1M
4.49%
YTD
8.83%
6M
9.51%
1Y
24.74%
3Y*
19.06%
5Y*
9.88%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PBPH vs. NZAC - Yearly Performance Comparison


Correlation

The correlation between PBPH and NZAC is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (All Time)
Calculated using the full available price history since Nov 26, 2025

0.44

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PBPH vs. NZAC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PBPH

NZAC
NZAC Risk / Return Rank: 5656
Overall Rank
NZAC Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
NZAC Sortino Ratio Rank: 5757
Sortino Ratio Rank
NZAC Omega Ratio Rank: 5555
Omega Ratio Rank
NZAC Calmar Ratio Rank: 4949
Calmar Ratio Rank
NZAC Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PBPH vs. NZAC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) and SPDR MSCI ACWI Climate Paris Aligned ETF (NZAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

PBPH vs. NZAC - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


PBPHNZACDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.92

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.59

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.71

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.04

0.61

-0.66

Drawdowns

PBPH vs. NZAC - Drawdown Comparison

The maximum PBPH drawdown since its inception was -11.10%, smaller than the maximum NZAC drawdown of -33.72%. Use the drawdown chart below to compare losses from any high point for PBPH and NZAC.


Loading charts...

Drawdown Indicators


PBPHNZACDifference

Max Drawdown

Largest peak-to-trough decline

-11.10%

-33.72%

+22.62%

Max Drawdown (1Y)

Largest decline over 1 year

-10.10%

Max Drawdown (3Y)

Largest decline over 3 years

-16.19%

Max Drawdown (5Y)

Largest decline over 5 years

-28.31%

Max Drawdown (10Y)

Largest decline over 10 years

-33.72%

Current Drawdown

Current decline from peak

-8.69%

-0.82%

-7.87%

Average Drawdown

Average peak-to-trough decline

-4.23%

-5.32%

+1.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.32%

Volatility

PBPH vs. NZAC - Volatility Comparison


Loading charts...

Volatility by Period


PBPHNZACDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.72%

Volatility (6M)

Calculated over the trailing 6-month period

10.34%

Volatility (1Y)

Calculated over the trailing 1-year period

16.78%

12.94%

+3.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.78%

16.81%

-0.03%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.78%

17.14%

-0.36%

PBPH vs. NZAC - Expense Ratio Comparison

PBPH has a 0.13% expense ratio, which is higher than NZAC's 0.12% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.


Dividends

PBPH vs. NZAC - Dividend Comparison

PBPH's dividend yield for the trailing twelve months is around 0.09%, less than NZAC's 2.04% yield.


PositionTTM20252024202320222021202020192018201720162015
NZAC
SPDR MSCI ACWI Climate Paris Aligned ETF
2.04%1.90%1.88%1.65%1.81%1.62%1.59%2.17%2.53%2.20%2.00%2.40%
PBPH
Portfolio Building Block World Pharma and Biotech Index ETF
0.09%0.09%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


PBPH and NZAC have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, NZAC is cheaper at 0.12% per year. The better choice depends on whether you care most about return, fees, risk, or income.

NZAC is cheaper with a 0.12% expense ratio, compared with 0.13% for PBPH.

NZAC has the higher dividend yield at 2.04%, compared with 0.09% for PBPH.

PBPH is categorized as Health & Biotech Equities, while NZAC is Global Equities. PBPH tracks BITA Global Pharma and Biotech Select Index, while NZAC tracks MSCI ACWI Climate Paris Aligned Index. They also come from different issuers: Portfolio Building Block and State Street. Their fees differ too: 0.13% for PBPH and 0.12% for NZAC.

Portfolio Optimizer

Find the right allocation for PBPH and NZAC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer